Search
for
Sort by
Research 451–480 of 741
- FOX FORDYCE DISEASE IN A PREPUBERTAL GIRL
- Clinical study of fibrosing alopecia in a pattern distribution in a Latin American population
- Pigmented contact dermatitis due to therapeutic sensitizer as complication of contact immunotherapy in alopecia areata
- GEOGRAPHIC TONGUE IN TWO CHILDREN WITH NONPUSTULAR PSORIASIS
- Frontal fibrosing alopecia after antiandrogen hormonal therapy in a male patient
- CUTANEOUS MASTOCYTOSIS IN CHILDREN: AN INDIAN EXPERIENCE
- Fibrosing Alopecia in a Pattern Distribution: A Case Report and Literature Review
- Finasteride in Frontal Fibrosing Alopecia: Joining the Dots!
- Reply
- Clinical, trichoscopic, and histological characteristics of 46 hispanic men with fibrosing alopecia in a pattern distribution: a retrospective multicenter analysis
- Quality of Life in Patients with Diffuse Lichen Planopilaris: A Cross-Sectional Study of 87 Moroccan Cases
- Coexistence of Lichen Planus Pigmentosus and Classic Lichen Planopilaris: A Case Report and Literature Review
- Expression of COX-2 and Bcl-2 in 50 patients of Lichen Planus
- PATTERN OF CUTANEOUS MANIFESTATIONS OF DIABETES MELLITUS
- ALOPECIA AREATA IN INFANTS: IS IT UNCOMMON?
- Contents
- Eczémas de contact atypiques ou sévères à l’huile essentielle de cannelle
- Phototherapy in pediatric patients: 5-years single center experience
- Apoptosis in human skin development: Morphogenesis, periderm, and stem cells
- Female pattern hair loss
- Telogen Effluvium
- Frontal fibrosing alopecia in postmenopausal women
- Efficacy and safety of omeprazole for severe gastroesophageal reflux in children
- Obesity and the skin
- Oxidative stress in ageing of hair
- Aging of hair
- Frontal fibrosing alopecia: A retrospective review of 19 patients seen at Duke University
- Frontal fibrosing alopecia associated with cutaneous lichen planus in a premenopausal woman
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors